Flagship Pioneering Inc.

Filings by Flagship Pioneering Inc. span 2 companies, the busiest being Omega Therapeutics, Inc. and Sana Biotechnology, Inc. Over a trading history stretching from 3 August 2021 to 13 September 2023, the count stands at 4 filings.

On the market, this insider has only ever bought: 1 purchase, €10.9M in total. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Since January 2023: 1 purchase and no sales on the market.

The newest entry dates from 15 September 2023: a transaction, in Sana Biotechnology, Inc. The most recent open-market purchase was published on 27 February 2023, 1,329 days ago. The median gap between a trade and its publication by SEC (Form 4) is 2 days. For comparison, the SEC allows two business days to file a Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.